400
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2029
Targeted Lung Denervation (TLD)
Targeted Lung Denervation (TLD)Therapy is a bronchoscopically guided, minimally invasive procedure using the Nuvaira™ Lung Denervation System.
Standard medical care
Continuing standard of care COPD maintenance medication that minimally includes LABA/ICS, LAMA/LABA or LABA/LAMA/ICS.
Lead Sponsor
Collaborators (1)
University of Alabama at Birmingham
OTHER
Temple Health
UNKNOWN
Ohio State University
OTHER
Honor Health - Clinical Trials
UNKNOWN
Medical College of Wisconsin
OTHER
University of Pittsburgh Medical Center
OTHER
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Nuvaira, Inc.
INDUSTRY